Bernstein Harold

CIK 0002050172

President, R&D & CMO

Filings

Latest Jun 3, 2026

Issuers covered

Showing

11 of 11

Page 1

Track record

17 of 20 open-market trades scored (85% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	17	71%	+10.4%	+0.1%	+45.4%	-24.6%
90 days	9	100%	+34.2%	+29.8%	+42.1%	+24.9%
180 days	-	-	-	-	-	-
365 days	-	-	-	-	-	-

Issuers

Companies where Bernstein Harold has filed

Ticker	Issuer	Filings	Last filed
MAZE	Maze Therapeutics, Inc.	11	Jun 3, 2026

All filings

11 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Jun 3, 2026	MAZEMaze Therapeutics, Inc.	SSale	13,253	$25.5746	$338,940
May 18, 2026	MAZEMaze Therapeutics, Inc.	SSale	15,000	$26.2236	$393,354
Apr 2, 2026	MAZEMaze Therapeutics, Inc.	SSale	11,352	$29.2414	$331,948
Mar 20, 2026	MAZEMaze Therapeutics, Inc.	SSale	6,161	$48.2027	$296,977
Mar 12, 2026	MAZEMaze Therapeutics, Inc.	SSale	29,652	$50.4454	$1,495,807
Mar 3, 2026	MAZEMaze Therapeutics, Inc.	Holdings only	-	-	-
Feb 4, 2026	MAZEMaze Therapeutics, Inc.	SSale	8,364	$45.8891	$383,816
Jan 9, 2026	MAZEMaze Therapeutics, Inc.	SSale	25,156	$40.2011	$1,011,299
Jan 6, 2026	MAZEMaze Therapeutics, Inc.	SSale	4,432	$40.4304	$179,188
Dec 31, 2025	MAZEMaze Therapeutics, Inc.	SSale	27,800	$40.339	$1,121,424
Sep 24, 2025	MAZEMaze Therapeutics, Inc.	Holdings only	-	-	-

Showing 1-11 of 11

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value